EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structural Genomics Defines PBRM1 Bromodomain Variant Function in ccRCC

Karina L Bursch iD, Salomão D Jorge iD, Audrey E Catlin, Raymundo Nuñez iD, Michael D LeClaire iD, Jacob Licklider, Raul A Urrutia iD, Brian C Smith iD

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/9214621 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, online erschienen am 05.08.2026. Verfasst von Karina L Bursch und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA, mcw.edu. Hauptthemen laut MEDLINE: Transcription Factors, Nuclear Proteins, Genomics, Carcinoma, Renal Cell. Die Arbeit nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polybromo‐1 (PBRM1) modulates chromatin accessibility and transcription via six bromodomains that bind acetyl‐lysine residues on nuclear proteins. PBRM1 variants exist in ~40% of clear cell renal cell carcinoma (ccRCC) cases. PBRM1 loss correlates with improved responses to antiangiogenics and immune checkpoint blockade, which are the standard of care for ccRCC therapy. Missense variants cluster within PBRM1 bromodomains and are present in 16% of ccRCC cases, with unknown impacts on therapeutic response. Since in‐depth biophysical and cellular testing of the hundreds of PBRM1 missense variants reported in ccRCC and other cancer types is intractable, computational approaches can provide actionable variant impact assessments. We employed an integrated structural genomics analysis at the levels of protein sequence (2D), structure (3D), and molecular dynamics (4D) to evaluate the effects of all reported ccRCC‐associated missense variants in the second and fourth bromodomains of PBRM1 (33 total) on molecular fitness (i.e., stability, structural integrity, and ligand binding). We also evaluated the concordance between molecular fitness and biophysical parameters of variant structural integrity (differential scanning fluorimetry, circular dichroism, and 1 H‐NMR spectroscopy) and ligand binding (AlphaScreen and electrophoretic mobility shift assays). Integrated molecular fitness scores correlated with measures of acetylated histone binding, while 3D and integrated molecular fitness scores correlated with measures of thermal stability. This integrated structural genomics analysis accelerates mechanistic understanding of how ccRCC missense variants impact PBRM1 bromodomain structure and function. This knowledge supports future studies correlating specific missense variants with PBRM1 tumor‐suppressive functions and patient responses to antiangiogenics and immune checkpoint blockade to inform ccRCC personalized medicine approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsNuclear ProteinsGenomicsCarcinoma, Renal CellKidney NeoplasmsHumansDNA-Binding ProteinsProtein DomainsMutation, MissenseMolecular Dynamics SimulationProtein Binding

Substanzen

PBRM1 protein, humanTranscription FactorsDNA-Binding ProteinsNuclear Proteins

Autor:innen und Institutionen

  • Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA, mcw.edu.
  • Structural Genomics Unit, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA, mcw.edu.
  • Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin, USA, mcw.edu.
  • Program in Chemical Biology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA, mcw.edu.

ORCID-Profile: Karina L Bursch, Salomão D Jorge, Raymundo Nuñez, Michael D LeClaire, Raul A Urrutia, Brian C Smith

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Cancer Institute
  • National Institute of General Medical Sciences

Zitieren

APA

Bursch, K. L., Jorge, S. D., Catlin, A. E., Nuñez, R., LeClaire, M. D., Licklider, J., Urrutia, R. A., & Smith, B. C. (2026). Structural Genomics Defines PBRM1 Bromodomain Variant Function in ccRCC. Human Mutation, 2026(1). https://doi.org/10.1155/humu/9214621

Vancouver

Bursch KL, Jorge SD, Catlin AE, Nuñez R, LeClaire MD, Licklider J, et al. Structural Genomics Defines PBRM1 Bromodomain Variant Function in ccRCC. Human Mutation. 2026;2026(1). doi:10.1155/humu/9214621

BibTeX
@article{Bursch2026,
  author = {Bursch, Karina L and Jorge, Salomão D and Catlin, Audrey E and Nuñez, Raymundo and LeClaire, Michael D and Licklider, Jacob and Urrutia, Raul A and Smith, Brian C},
  title = {Structural Genomics Defines PBRM1 Bromodomain Variant Function in ccRCC},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/9214621}
}
Kostenlos starten →